-
2024-516415-24-03
General anesthesia 6
-
2025-524725-41-00
Acute Myeloblastic Leukemia 3
-
2024-518795-31-00
Adult patients (> 18 years of age) undergoing palliativ 10
-
2025-522944-41-00
Solid Tumours 7
-
2024-519895-23-00
To analyze whether the anti-rejection treatment of bord 10
-
2025-523760-21-00
Metastatic or advanced malignant solid tumors 1
-
2024-515605-26-00
No medical condition. 2
-
2025-524832-20-00
Healthy volunteers 3
-
2023-509931-15-00
Patients (male or female) ≥18 years old with scalp and 11
-
2024-519403-10-00
Female contraception. 6
-
2024-519472-69-00
CML-Patients in chronic phase having failed a prior att 4
-
2025-522410-23-00
open abdomen 6
-
2024-514373-22-00
Healthy volunteers 3
-
2023-504870-39-00
drug-drug interactions (DDI) 3
-
2023-505907-21-00
Healthy volunteers 4
-
2024-511047-26-01
Stable health without uncontrolled systemic diseases; H 6
-
2023-505380-36-01
Patients with stage I, II, III hormone-receptor positiv 5
-
2023-506965-72-00
Parkinson Disease 1
-
2025-523146-27-00
Herpes simplex virus encephalitis 3
-
2024-511585-36-00
pediatric kidney transplant recipients 6
-
2024-519529-40-00
ESOPHAGOYEJUNAL ANASTOMOSIS DEHISCENCE IN TOTAL GASTREC 5
-
2025-522491-89-00
Chronic Kidney Disease 4
-
2025-522498-12-00
iron deficiency in adolescent girls 6
-
2025-523193-16-00
Healthy volunteer trial 3